1. Home
  2. SCYX vs SIDU Comparison

SCYX vs SIDU Comparison

Compare SCYX & SIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • SIDU
  • Stock Information
  • Founded
  • SCYX 1999
  • SIDU 2012
  • Country
  • SCYX United States
  • SIDU United States
  • Employees
  • SCYX N/A
  • SIDU N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • SIDU Telecommunications Equipment
  • Sector
  • SCYX Health Care
  • SIDU Telecommunications
  • Exchange
  • SCYX Nasdaq
  • SIDU Nasdaq
  • Market Cap
  • SCYX 36.8M
  • SIDU 29.5M
  • IPO Year
  • SCYX 2014
  • SIDU 2021
  • Fundamental
  • Price
  • SCYX $0.88
  • SIDU $1.40
  • Analyst Decision
  • SCYX
  • SIDU
  • Analyst Count
  • SCYX 0
  • SIDU 0
  • Target Price
  • SCYX N/A
  • SIDU N/A
  • AVG Volume (30 Days)
  • SCYX 204.8K
  • SIDU 451.1K
  • Earning Date
  • SCYX 05-15-2025
  • SIDU 05-15-2025
  • Dividend Yield
  • SCYX N/A
  • SIDU N/A
  • EPS Growth
  • SCYX N/A
  • SIDU N/A
  • EPS
  • SCYX N/A
  • SIDU N/A
  • Revenue
  • SCYX $2,630,000.00
  • SIDU $3,860,985.00
  • Revenue This Year
  • SCYX $460.12
  • SIDU $144.49
  • Revenue Next Year
  • SCYX $253.87
  • SIDU N/A
  • P/E Ratio
  • SCYX N/A
  • SIDU N/A
  • Revenue Growth
  • SCYX N/A
  • SIDU N/A
  • 52 Week Low
  • SCYX $0.72
  • SIDU $1.14
  • 52 Week High
  • SCYX $2.60
  • SIDU $7.65
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 48.64
  • SIDU 40.90
  • Support Level
  • SCYX $0.72
  • SIDU $1.43
  • Resistance Level
  • SCYX $1.02
  • SIDU $2.00
  • Average True Range (ATR)
  • SCYX 0.08
  • SIDU 0.12
  • MACD
  • SCYX 0.00
  • SIDU -0.02
  • Stochastic Oscillator
  • SCYX 51.70
  • SIDU 6.25

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

Share on Social Networks: